Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
6.6
4.9
Journals
Biosensors
Special Issues
Aptamers to Replace Antibodies for in vitro Diagnostics
share announcement

Aptamers to Replace Antibodies for in vitro Diagnostics

A special issue of Biosensors (ISSN 2079-6374). This special issue belongs to the section "Biosensors and Healthcare".

Deadline for manuscript submissions: closed (31 December 2020) | Viewed by 19734

Special Issue Editors

Dr. Yoann Roupioz

E-Mail Website
Guest Editor
SyMMES, UMR 5819 (Uni. Grenoble Alpes, CEA, CNRS), 17 Rue des Martyrs, 38000 Grenoble, France
Interests: surface functionalisation; development of cell biochips, bacteria biochips; cellular monitoring on-the-chip; surface treatments ensuring bio-compatibility; aptamer-based biochips
Dr. Arnaud Buhot

E-Mail Website
Guest Editor
Grenoble Alpes University, CEA, CNRS, IRIG-SyMMES, 17 Rue des Martyrs, 38000 Grenoble, France
Interests: optoelectronic nose/tongue development; aptamer biosensors; surface plasmons resonance imaging; theory of microarrays (DNA or protein); biopolymer conformation; DNA based architectures; soft condensed matter
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Among the different detection modes, the gold standard for biomarkers remains the enzyme-linked immunosorbent assay (ELISA). Its development more than fifty years ago and its sensitivity explain its widespread use in diagnostic applications. In particular, ELISA consists of a sandwich over the target between a target-capturing antibody and a detection antibody. Furthermore, ELISA is generally associated to a secondary antibody to generate an enzymatically amplified signal. However, antibodies as probes convey various drawbacks. In addition to batch-to-batch variations in their production, specific antibodies are tedious, costly, and challenging to generate. Furthermore, their shelf life can limit their incorporation, as embedded reagents in medical devices and their chemical modifications are particularly difficult in order to develop alternatives to the traditional enzymatic amplifications. These problems highlight the need for an alternative to antibodies in order to improve or to bypass ELISA.

Since their discovery in 1990, aptamers have appeared as an ideal alternative to antibodies in diagnostic applications. Aptamers are short oligonucleotides selected from a large library of random sequences for their specificity towards a target (SELEX method). Their 3D conformation confers to aptamers strong sensitivity and selectivity. In vitro selection allows the recognition of a large variety of targets ranging from ions, small molecules, proteins up to cells. The large-scale in vitro synthesis of aptamers ensures the low-cost production of the future reagents with a large set of possible chemical modifications of sequences. Finally, their chemical stability provides numerous opportunities for their integration in point-of-care medical devices such as paper strips or microfluidic cartridges.

Despite all those advantages, up to now, aptamers have failed to replace antibodies. The aim of this Special Issue is to provide a state-of-the-art situation of the developments of aptamers as probes, the detection modes associated for in vitro diagnostics, and their integration in medical devices. Papers addressing the remaining challenges and hurdles still to overcome in order to access the IVD market are also welcome.

Dr. Yoann Roupioz
Dr. Arnaud Buhot
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biosensors is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • aptamers
  • in vitro diagnostics (IVD)
  • medical devices
  • biomarkers

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (4 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review, Other

14 pages, 2295 KiB  
Article
Melting Curve Analysis of Aptachains: Adenosine Detection with Internal Calibration
by Chenze Lu, Christine Saint-Pierre, Didier Gasparutto, Yoann Roupioz, Corinne Ravelet, Eric Peyrin and Arnaud Buhot
Biosensors 2021, 11(4), 112; https://doi.org/10.3390/bios11040112 - 8 Apr 2021
Cited by 6 | Viewed by 3079
Abstract
Small molecules are ubiquitous in nature and their detection is relevant in various domains. However, due to their size, sensitive and selective probes are difficult to select and the detection methods are generally indirect. In this study, we introduced the use of melting [...] Read more.
Small molecules are ubiquitous in nature and their detection is relevant in various domains. However, due to their size, sensitive and selective probes are difficult to select and the detection methods are generally indirect. In this study, we introduced the use of melting curve analysis of aptachains based on split-aptamers for the detection of adenosine. Aptamers, short oligonucleotides, are known to be particularly efficient probes compared to antibodies thanks to their advantageous probe/target size ratio. Aptachains are formed from dimers with dangling ends followed by the split-aptamer binding triggered by the presence of the target. The high melting temperature of the dimers served as a calibration for the detection/quantification of the target based on the height and/or temperature shift of the aptachain melting peak. Full article
(This article belongs to the Special Issue Aptamers to Replace Antibodies for in vitro Diagnostics)
►▼ Show Figures

Figure 1

Review

Jump to: Research, Other

28 pages, 2577 KiB  
Review
Advances in Electrochemical and Acoustic Aptamer-Based Biosensors and Immunosensors in Diagnostics of Leukemia
by Tibor Hianik
Biosensors 2021, 11(6), 177; https://doi.org/10.3390/bios11060177 - 31 May 2021
Cited by 21 | Viewed by 5176
Abstract
Early diagnostics of leukemia is crucial for successful therapy of this disease. Therefore, development of rapid, sensitive, and easy-to-use methods for detection of this disease is of increased interest. Biosensor technology is challenged for this purpose. This review includes a brief description of [...] Read more.
Early diagnostics of leukemia is crucial for successful therapy of this disease. Therefore, development of rapid, sensitive, and easy-to-use methods for detection of this disease is of increased interest. Biosensor technology is challenged for this purpose. This review includes a brief description of the methods used in current clinical diagnostics of leukemia and provides recent achievements in sensor technology based on immuno- and DNA aptamer-based electrochemical and acoustic biosensors. The comparative analysis of immuno- and aptamer-based sensors shows a significant advantage of DNA aptasensors over immunosensors in the detection of cancer cells. The acoustic technique is of comparable sensitivity with those based on electrochemical methods; moreover, it is label-free and provides straightforward evaluation of the signal. Several examples of sensor development are provided and discussed. Full article
(This article belongs to the Special Issue Aptamers to Replace Antibodies for in vitro Diagnostics)
►▼ Show Figures

Figure 1

19 pages, 1184 KiB  
Review
Aptasensors for Point-of-Care Detection of Small Molecules
by Marc Prante, Ester Segal, Thomas Scheper, Janina Bahnemann and Johanna Walter
Biosensors 2020, 10(9), 108; https://doi.org/10.3390/bios10090108 - 26 Aug 2020
Cited by 60 | Viewed by 7336
Abstract
Aptamers, a group of nucleic acids which can specifically bind to a target molecule, have drawn extensive interest over the past few decades. For analytics, aptamers represent a viable alternative to gold-standard antibodies due to their oligonucleic nature combined with advantageous properties, including [...] Read more.
Aptamers, a group of nucleic acids which can specifically bind to a target molecule, have drawn extensive interest over the past few decades. For analytics, aptamers represent a viable alternative to gold-standard antibodies due to their oligonucleic nature combined with advantageous properties, including higher stability in harsh environments and longer shelf-life. Indeed, over the last decade, aptamers have been used in numerous bioanalytical assays and in various point-of-care testing (POCT) platforms. The latter allows for rapid on-site testing and can be performed outside a laboratory by unskilled labor. Aptamer technology for POCT is not limited just to medical diagnostics; it can be used for a range of applications, including environmental monitoring and quality control. In this review, we critically examine the use of aptamers in POCT with an emphasis on their advantages and limitations. We also examine the recent success of aptasensor technology and how these findings pave the way for the analysis of small molecules in POCT and other health-related applications. Finally, the current major limitations of aptamers are discussed, and possible approaches for overcoming these challenges are presented. Full article
(This article belongs to the Special Issue Aptamers to Replace Antibodies for in vitro Diagnostics)
►▼ Show Figures

Figure 1

Other

Jump to: Research, Review

11 pages, 2281 KiB  
Letter
Effective Isolation for Lung Carcinoma Cells Based on Immunomagnetic Separation in a Microfluidic Channel
by Hien Vu-Dinh, Hui Feng and Chun-Ping Jen
Biosensors 2021, 11(1), 23; https://doi.org/10.3390/bios11010023 - 16 Jan 2021
Cited by 7 | Viewed by 3113
Abstract
In this paper, we developed an isolation system for A549 human lung carcinoma cells as an effective factor for the early diagnosis of lung cancer. A microfluidic immunomagnetic method was used, in which the combination of immunomagnetic separation and a microfluidic system allowed [...] Read more.
In this paper, we developed an isolation system for A549 human lung carcinoma cells as an effective factor for the early diagnosis of lung cancer. A microfluidic immunomagnetic method was used, in which the combination of immunomagnetic separation and a microfluidic system allowed for increased isolation efficiency with uncomplicated manipulation. In the microfluidic immunomagnetic strategy, A549 cells were combined with aptamer-conjugated carboxylated magnetic beads and then collected in a specified region by applying a magnetic field. The results were recorded using a fluorescence microscope, and the captured targets were then quantified. The isolation efficiency of A549 cells is up to 77.8%. This paper developed a simple working procedure, which is less time consuming, high-throughput, and trustworthy for the isolation of A549 cells. This procedure can be a useful reference method for the development of an effective diagnosis and treatment method for lung cancer in the future. Full article
(This article belongs to the Special Issue Aptamers to Replace Antibodies for in vitro Diagnostics)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-4
Back to TopTop